Article Information
History
- August 31, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ajai Chari1,#,
- Mehmet Kemal Samur2,#,
- Joaquin Martinez-Lopez3,
- Gordon Cook4,
- Noa Biran5,
- Kwee Yong6,
- Vania Hungria7,
- Monika Engelhardt8,
- Francesca Gay9,
- Ana García Feria10,
- Stefania Oliva11,
- Rimke Oostvogels12,
- Alessandro Gozzetti13,
- Cara Rosenbaum14,
- Shaji Kumar15,
- Edward A. Stadtmauer16,
- Hermann Einsele17,
- Meral Beksac18,
- Katja Weisel19,
- Kenneth C. Anderson20,
- María-Victoria Mateos21,
- Philippe Moreau22,
- Jesus San-Miguel23,*,
- Nikhil C. Munshi20,24,* and
- Hervé Avet-Loiseau25,*,†
- 1Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 2Dana Farber Cancer Institute and Harvard TH Chan School of Public Health, Boston, MA, USA
- 3Hospital Universitario 12 de Octubre, Octubre, i+12, CNIO, Complutense University, Madrid, Comunidad de Madrid, Spain
- 4Leeds Institute of Clinical Trial Research & Leeds Cancer Centre, University of Leeds, Leeds, UK
- 5John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA
- 6Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK
- 7Clínica São Germano, São Paulo, Brazil
- 8Medical Department, Hematology, Oncology & Stem Cell Transplantation, Clinical Cancer Research Group, Freiburg, Faculty of Freiburg, Freiburg, Germany
- 9Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Italy
- 10Department of Hematology, Hospital de Manises, Valencia, Spain
- 11University of Turin, Turin, Italy
- 12Department of Haematology, University Medical Centre, Utrecht, The Netherlands
- 13University of Siena, Department of Hematology, Siena, Italy
- 14Center for Myeloma, New York Presbyterian Hospital-Weill Cornell Medical Center, New York, NY, USA
- 15The Division of Hematology, Mayo Clinic, Rochester, MN, USA
- 16Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA
- 17Department of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany
- 18Department of Hematology, Ankara University, Ankara, Turkey
- 19II. Medizinische Klinik, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
- 20Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA
- 21University Hospital of Salamanca-Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain
- 22Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France and Intergroupe Francophone du Myélome (IFM)
- 23Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IDISNA), Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), Pamplona, Spain
- 24VA Boston Healthcare System, Boston, MA
- 25Centre de Recherche en Cancérologie de Toulouse INSERM U1037, Toulouse, France, and Intergroupe Francophone du Myélome (IFM)
- ↵†Corresponding Author:
Hervé Avet-Loiseau, MD, PhD, Centre de Recherche en Cancérologie de Toulouse INSERM U1037, Toulouse, France AvetLoiseau.Herve{at}iuct-oncopole.fr